1 heavy investment in research and development, the world's new anti-cancer drugs, half in the United States. If cancer is compared to a cunning enemy, then the anti-cancer drugs are the "weapons" to defeat the enemy. For cancer patients, there are drugs, there is hope. In the last decade, the research and development of targeted drugs and immunotherapy have given mankind a more powerful weapon in the arsenal against cancer, in addition to surgery, radiotherapy and chemotherapy. Statistics: The five-year survival rate of cancer in the United States is 66%, while that of China is 30.9%. And the medicine is cancer patients "life" of the fundamental.
2 Spare no effort to popularize cancer screening. The purpose of cancer screening is not simply "early detection and early intervention", but the early detection of malignant lesions or lesions that may progress to malignant tumors. Only through individualized screening can the mortality rate associated with a particular cancer be truly reduced. In China, only 15% of people over 50 years of age undergo colonoscopy, and there is still plenty of room for improvement. In addition, lung cancer screening for high-risk groups should also attract attention. Research in the United States has found that people at high risk for lung cancer (who have smoked or currently smoke more than 30 packs per year) can reduce their mortality rate by 20% if they undergo annual low-dose spiral CT screening for lung cancer.
3 Extreme efforts are made to avoid erroneous, overdiagnosis. In the United States, pathologic diagnosis is the "gold standard" of cancer care and the cornerstone of all treatment. Since 2010, the number of prostate cancer patients in the United States has dropped dramatically. The main reason for this is a reduction in overdiagnosis. Cancer treatment is a comprehensive process, rather than relying on a surgical "one knife" or authoritative professor, the United States is more teamwork. In authoritative hospitals in the U.S., the system of "multidisciplinary treatment" (also called MDT) is commonly practiced today. A typical U.S. cancer treatment team, there are different echelons of medical personnel: the upper echelon of the team of doctors, according to the patient's condition, medical oncologists, surgical oncologists, oncology radiotherapists, etc. will be combined together to form a targeted medical team.